Reading Room Production — page 457
of 496 pages
← p.456 p.458 → · this page in the original PDF · package
From: Korch, George (OS)
Sent: Saturday, January 30, 2010 1:58 PM
To:
@who.eop.gov;
@who.eop.gov; Emanuel, Ezekiel (NIH/CC/BEP) [E]; Ezekiel
Emanuel; Lurie, Nicole (OS); Fauci, Anthony (NIH/NIAID) [E]; Robinson, Robin (OS); Merchant, Raina (HHS/ASPR);
Borio, Luciana L (FDA)
Cc: Korch, George (OS)
Subject: Synopsis of Conversation with Pharma/Bio Reps 29 Jan 2010
Heidi, et al.:
I have summarized the conversation with the VP's and representatives from the pharmaceutical / biotechnology industries
regarding incentives promoting greater participation by industry in our public health emergency medical countermeasure
enterprise. Where possible, I identify follow-on actions that derive directly from the conversation. There are still
important conversations to continue with our commercial partners. Please feel free to modify or add information or
perspectives that I did not adequately capture. Also, I did not quote by name the discussions offered by our industrial
partners.
Best regards
George
George W. Korch Jr.
Senior Science Advisor
Assistant Secretary for Preparedness and Response
Department of Health & Human Services
This is our OCR of the page, with running headers and footers removed. The
Committee's PDF
is authoritative; quote from it. Machine-readable, including the uncleaned
text: /api/page/reading_room/457
Records on this page
| Record | Date | Type | Pages |
|---|---|---|---|
| Synopsis of Conversation with Pharma/Bio Reps 29 Jan 2010 | 2010-01-30 | 457 |